Disclaimer
The alfapump® system is currently not approved in the United States or Canada. In the United States and Canada, the alfapump® system is currently under clinical investigation (POSEIDON Study) and is being studied in adult patients with refractory or recurrent ascites due to cirrhosis. DSR® therapy is still in development and it should be noted that any statements regarding safety and efficacy arise from ongoing pre-clinical and clinical investigations which have yet to be completed. There is no link between the DSR® therapy and ongoing investigations with the alfapump® system in Europe, the United States or Canada.
Sequana Medical NV
Kortrijksesteenweg 1112 box 102
9051 Sint-Denijs-Westrem
Swiss Authorized Representative (CH-REP)
Sequana Medical NV
Technoparkstrasse 1
Building Darwin, 2nd floor
8005 Zurich
Sequana Medical GmbH
Rundfunkplatz 2
80335 München
Sequana Medical US Inc
265 Franklin Street , Suite 1702
Boston, MA 02110
For enquiries or to request information material, please use the contact form below.
United Kingdom
0800 069 84 89
Switzerland
+41 44403 55 29